Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 173–173 | Cite as

Mepolizumab

Generalised urticaria with asthenia and arthralgias: case report
Case report
  • 10 Downloads

Reference

  1. Lombardi C, et al. Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulmonary Pharmacology and Therapeutics 54: 87-89, Feb 2019. Available from: URL: http://doi.org/10.1016/j.pupt.2018.12.003 - ItalyCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations